+289.3%
FN vs SBAC
-43.7%
+333.0%
-47.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +3.1% | -1.1% | +4.2% | +3.2% |
| 7D | -1.7% | -0.8% | -0.9% | -1.6% |
| 30D | -22.0% | +6.9% | -28.9% | -22.5% |
| 3M | -43.0% | -8.2% | -34.8% | -42.5% |
| 6M | -27.7% | -1.6% | -26.1% | -28.1% |
| YTD | -10.5% | -0.1% | -10.4% | -11.2% |
| 1Y | +12.5% | -0.5% | +12.9% | +11.7% |
| 3Y | +153.8% | -9.1% | +162.9% | +147.5% |
| All | +289.3% | -43.7% | +333.0% | +337.0% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling